Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01)
Funding Opportunity ID: 292073 Opportunity Number: RFA-DE-18-004 Opportunity Title: Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.121Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authori...
Source: Grants.gov - February 27, 2017 Category: Research Tags: Health Source Type: funding

Neoantigen-Based Therapeutic Targeting of Head and Neck Cancers (R01)
Funding Opportunity RFA-DE-18-004 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support basic and preclinical research aimed at developing novel immunotherapeutic targets for head and neck cancers (HNC), including salivary gland cancers. Research supported by this FOA will identify human HNC-specific neoantigens, and will test the utility of these neoantigens as targets for eliciting anti-tumor immune responses in affected patient populations. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 27, 2017 Category: Research Source Type: funding